Cibus (CBUS) vs Evogene (EVGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cibus is the larger company by market cap ($123.8 million vs $6.5 million), about 19.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CBUS | EVGN |
|---|---|---|
| Share price | $1.62 | $0.4106 |
| Market cap | $123.81M | $6.49M |
| 1-day change | +3.18% | -3.09% |
| YTD return | -6.90% | — |
| 1-year return | +13.29% | — |
| 5-year return | -98.90% | — |
| EPS (TTM) | $-1.65 | $-1.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.19 | $1.50 |
| 52-week low | $1.09 | $0.35 |
| Distance from 52-week high | -61.35% | -72.63% |
| Analyst consensus | none | — |
| Avg. price target upside | +784.57% | — |
| Average volume | 208.04K | 2.02M |
| Shares outstanding | 76.43M | 15.80M |
| Employees | 118 | — |
| Sector | Healthcare | Industrials |
| Industry | Biotechnology | Agricultural Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cibus is about 19.1 times larger than Evogene by market value ($123.81M vs $6.49M).
- The two companies sit in different sectors: Cibus in Healthcare and Evogene in Industrials.
About Cibus
CBUS stock →Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
Healthcare · Biotechnology · 118 employees
CBUS vs EVGN FAQ
Which is bigger, Cibus or Evogene?
Cibus (CBUS) is larger, with a market capitalization of $123.81M compared with $6.49M for Evogene (EVGN).
Are Cibus and Evogene in the same industry?
No. Cibus is in the Healthcare sector, while Evogene is in Industrials.